Clinical study of Baduanjin combined with mecobalamin tablets for the patients with type 2 diabetic peripheral neuropathy
10.3760/cma.j.cn115398-20210518-00177
- VernacularTitle:八段锦结合甲钴胺片治疗2型糖尿病周围神经病变临床研究
- Author:
Yi CHEN
1
,
2
;
Yanfeng LI
;
Yimiao GAN
;
Wenlan GAO
;
Feng TAO
;
Yang SUN
;
Xiao ZHENG
Author Information
1. 上海中医药大学附属市中医医院内分泌科，上海
2. 200071
- Keywords:
Diabetes mellitus, type 2;
Diabetes complications;
Baduanjin;
Mecobalamin;
Exercise therapy;
Qigong (TCM)
- From:
International Journal of Traditional Chinese Medicine
2022;44(1):38-42
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the efficacy of Baduanjin combined with mecobalamin tablets in the treatment of type 2 diabetic peripheral neuropathy. Methods:Eighty patients with type 2 diabetic peripheral neuropathy who met the inclusion criteria were randomly divided into two groups with 40 patients in each group ( n=40). The control group took oral mecobalamin tablets and self-management, and the treatment group were treated with Baduanjin on the basis of the control group. All patients were treated for 12 weeks. The clinical symptoms were evaluated by Toronto Clinical Scoring System (TCSS), and the motor nerve conduction velocity (MCV) of tibial nerve and the sensory conduction velocity (SCV) of superficial peroneal nerve were measured by EMG evoked potential instrument. The hemorheological indexes (whole blood low shear viscosity, whole blood high shear viscosity and plasma viscosity) were measured before and after treatment. The clinical efficacy was evaluated and adverse events were recorded. Results:In the course of treatment, 39 patients in each group completed the study with each one dropout. The total effective rate was 87.2% (34/39) in the treatment group and 64.1% (25/39) in the control group. There was significant difference between the two groups ( χ2=5.64, P=0.018). After treatment, the TCSS score of the treatment group was significantly lower than that of the control group ( t=-6.23, P<0.01), the tibial nerve MCV (43.06 ± 4.19 m/s vs. 39.55 ± 4.30 m/s, t=3.65), the superficial peroneal nerve SCV (43.23 ± 4.31 m/s vs. 39.92 ± 3.74 m/s, t=3.62) in the treatment group were significantly higher than the control group ( P<0.001), while the whole blood high shear viscosity, the whole blood low shear viscosity, and the plasma viscosity in the treatment group were significantly lower than the control group ( t value were -10.36, -14.21, -13.88, all Ps<0.001). During the treatment, no serious adverse events occurred in both groups. Conclusion:Baduanjin combined with mecobalamin tablets in the treatment of type 2 diabetic peripheral neuropathy can reduce blood viscosity, promote blood circulation, increase nerve conduction velocity, improve clinical symptoms and signs, and improve clinical efficacy.
